PubMed COVID-19 Clinical Care

No abstract

No abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded enveloped positive RNA virus and the cause of the ongoing coronavirus disease 2019 (COVID-19) pandemic. Chloroquine (CQ), an antimalarial drug, was reported to be

新型冠状病毒感染（2019 novel coronavirus disease，COVID-19）由严重急性呼吸综合征冠状病毒2引起，临床症状多样，合并嗅觉功能障碍的病例也被越来越多地报道。本文回顾了现有的国内外相关文献，总结了COVID-19相关嗅觉障碍的发病情况、潜在机制、治疗措施和预后，以期对COVID-19相关嗅觉障碍提供研究现状全景，并提示未来可能的研究方向。.

Since the early phase of the coronavirus disease 2019 (COVID-19) pandemic, a number of research institutes have been sequencing and sharing high-quality severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomes to trace the route of

Myocardial injury is one of the most common comorbidity in SARS-CoV-2 infected patients, and has poor prognosis. However, the incidence of myocardial injury in patients with SARS-CoV-2 infection has not been sufficiently investigated during the

The COVID-19 pandemic disrupted the college transition process and first year college experience for several cohorts of students. This review addresses research related to the college transition process, illustrating the "high touch" support

No abstract

No abstract

The SARS-CoV-2 virus gains entry into human cells by exploiting the angiotensin-converting enzyme 2 (ACE2), a key component known as the spike protein (S), as a point of entry. Initially, SARS-CoV-2 suppresses the natural function of ACE2, leading to